[{"id":"ad67aba0-0a78-4409-a9da-54568d0c4622","acronym":"","url":"https://clinicaltrials.gov/study/NCT06505356","created_at":"2025-02-27T07:48:10.382Z","updated_at":"2025-02-27T07:48:10.382Z","phase":"","brief_title":"Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association With Disease Stage","source_id_and_acronym":"NCT06505356","lead_sponsor":"Edgaras Burzinskis","biomarkers":" IFNG • IL6 • TNFA • IL2 • IL10 • CCL19 • IL18 • CTBP2 • GAS5 • JAZF1","pipe":"","alterations":" ","tags":["IFNG • IL6 • TNFA • IL2 • IL10 • CCL19 • IL18 • CTBP2 • GAS5 • JAZF1"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 400","initiation":"Initiation: 09/01/2024","start_date":" 09/01/2024","primary_txt":" Primary completion: 08/30/2028","primary_completion_date":" 08/30/2028","study_txt":" Completion: 08/30/2028","study_completion_date":" 08/30/2028","last_update_posted":"2024-07-17"},{"id":"8e400406-6f6a-4f41-824d-61725c09b480","acronym":"CICPD","url":"https://clinicaltrials.gov/study/NCT04381741","created_at":"2021-01-18T21:09:36.209Z","updated_at":"2024-07-02T16:35:56.413Z","phase":"Phase 1","brief_title":"CD19 CAR-T Expressing IL7 and CCL19 Combined With PD1 mAb for Relapsed or Refractory Diffuse Large B Cell Lymphoma","source_id_and_acronym":"NCT04381741 - CICPD","lead_sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","biomarkers":" CD20 • CD19 • PD-1 • CCL19 • IL7","pipe":" | ","alterations":" CD19 expression","tags":["CD20 • CD19 • PD-1 • CCL19 • IL7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Tevimbra (tislelizumab-jsgr) • CD19-7×19 CAR-T"],"overall_status":"Enrolling by invitation","enrollment":" Enrollment 24","initiation":"Initiation: 06/18/2020","start_date":" 06/18/2020","primary_txt":" Primary completion: 09/01/2023","primary_completion_date":" 09/01/2023","study_txt":" Completion: 09/01/2023","study_completion_date":" 09/01/2023","last_update_posted":"2023-02-06"},{"id":"110ea52b-e84e-4c4f-ac59-5c89e4d16963","acronym":"EPITHEM","url":"https://clinicaltrials.gov/study/NCT04576429","created_at":"2021-01-18T21:50:49.552Z","updated_at":"2024-07-02T16:36:16.766Z","phase":"","brief_title":"Immune Profiles Evolution Under Immunotherapy for Melanoma","source_id_and_acronym":"NCT04576429 - EPITHEM","lead_sponsor":"Assistance Publique - Hôpitaux de Paris","biomarkers":" VEGFA • IFNG • IL6 • TNFA • CXCL10 • IL2 • CCL20 • IL10 • CCL19 • CCL2 • GZMB • IL17A • IL1A • IFNA1 • IL1B • IL1RN • TGFA • TNFSF10 • CXCL1 • IL33","pipe":"","alterations":" ","tags":["VEGFA • IFNG • IL6 • TNFA • CXCL10 • IL2 • CCL20 • IL10 • CCL19 • CCL2 • GZMB • IL17A • IL1A • IFNA1 • IL1B • IL1RN • TGFA • TNFSF10 • CXCL1 • IL33"],"overall_status":"Recruiting","enrollment":" Enrollment 360","initiation":"Initiation: 01/27/2021","start_date":" 01/27/2021","primary_txt":" Primary completion: 01/01/2031","primary_completion_date":" 01/01/2031","study_txt":" Completion: 01/01/2031","study_completion_date":" 01/01/2031","last_update_posted":"2022-02-23"},{"id":"36dae252-34db-4379-9046-72e155c4512d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04833504","created_at":"2021-04-06T11:55:29.016Z","updated_at":"2024-07-02T16:36:32.311Z","phase":"","brief_title":"Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma","source_id_and_acronym":"NCT04833504","lead_sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","biomarkers":" CCL19 • IL7","pipe":"","alterations":" ","tags":["CCL19 • IL7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19-7×19 CAR-T"],"overall_status":"Completed","enrollment":" Enrollment 39","initiation":"Initiation: 07/01/2018","start_date":" 07/01/2018","primary_txt":" Primary completion: 10/01/2019","primary_completion_date":" 10/01/2019","study_txt":" Completion: 10/01/2020","study_completion_date":" 10/01/2020","last_update_posted":"2021-04-06"},{"id":"85862186-4d7e-480a-b17c-fdebf9d139f7","acronym":"","url":"https://clinicaltrials.gov/study/NCT03932565","created_at":"2021-01-18T19:22:13.474Z","updated_at":"2024-07-02T16:36:38.551Z","phase":"Phase 1","brief_title":"Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors","source_id_and_acronym":"NCT03932565","lead_sponsor":"The Sixth Affiliated Hospital of Wenzhou Medical University","biomarkers":" NECTIN4 • CCL19 • FAP","pipe":" | ","alterations":" NECTIN4 expression • FAP expression","tags":["NECTIN4 • CCL19 • FAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NECTIN4 expression • FAP expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CAR-T Targeting Nectin4/FAP"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 02/13/2019","start_date":" 02/13/2019","primary_txt":" Primary completion: 06/30/2021","primary_completion_date":" 06/30/2021","study_txt":" Completion: 12/31/2021","study_completion_date":" 12/31/2021","last_update_posted":"2020-11-18"},{"id":"08338ec0-6078-48e0-bc33-7c4d40eba740","acronym":"MEL58","url":"https://clinicaltrials.gov/study/NCT01585350","created_at":"2021-01-18T06:45:23.070Z","updated_at":"2024-07-02T16:37:29.831Z","phase":"Phase 1","brief_title":"A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients","source_id_and_acronym":"NCT01585350 - MEL58","lead_sponsor":"Craig L Slingluff, Jr","biomarkers":" MYD88 • CD8 • IFNG • TNFA • CXCL12 • CXCL9 • CD4 • CD69 • IL2 • CXCL13 • IL10 • CCL19 • FOXP3 • IL17A • IL23A • CCL21 • GATA3 • IL4 • IL5","pipe":"","alterations":" ","tags":["MYD88 • CD8 • IFNG • TNFA • CXCL12 • CXCL9 • CD4 • CD69 • IL2 • CXCL13 • IL10 • CCL19 • FOXP3 • IL17A • IL23A • CCL21 • GATA3 • IL4 • IL5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Hiltonol (poly-ICLC)"],"overall_status":"Completed","enrollment":" Enrollment 53","initiation":"Initiation: 10/01/2012","start_date":" 10/01/2012","primary_txt":" Primary completion: 07/01/2014","primary_completion_date":" 07/01/2014","study_txt":" Completion: 10/01/2014","study_completion_date":" 10/01/2014","last_update_posted":"2016-08-12"}]